Lewon-Mrozek D, Kurzynoga J, Jedrzejewski P, Kedzierska K, Partyka A, Kuriata-Kordek M
Int J Mol Sci. 2024; 25(23).
PMID: 39684839
PMC: 11642642.
DOI: 10.3390/ijms252313129.
Tripathy R, Khandave P, Bzdrenga J, Nachon F, Brazzolotto X, Pande A
Arch Toxicol. 2024; 99(2):447-465.
PMID: 39356346
DOI: 10.1007/s00204-024-03884-2.
Lampitella E, Marone M, Achanta N, Porzio E, Trepiccione F, Manco G
Molecules. 2024; 29(11).
PMID: 38893310
PMC: 11173892.
DOI: 10.3390/molecules29112434.
Campagna R, Serritelli E, Salvolini E, Schiavoni V, Cecati M, Sartini D
Biomolecules. 2024; 14(2).
PMID: 38397445
PMC: 10886763.
DOI: 10.3390/biom14020208.
Alsharairi N
Genes (Basel). 2023; 14(5).
PMID: 37239377
PMC: 10218220.
DOI: 10.3390/genes14051017.
Vutiglabridin Modulates Paraoxonase 1 and Ameliorates Diet-Induced Obesity in Hyperlipidemic Mice.
Sulaiman D, Choi L, Lee H, Shin J, Kim D, Lee K
Biomolecules. 2023; 13(4).
PMID: 37189434
PMC: 10135725.
DOI: 10.3390/biom13040687.
Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review.
Kunachowicz D, Sciskalska M, Kepinska M
Int J Environ Res Public Health. 2023; 20(4).
PMID: 36833509
PMC: 9957543.
DOI: 10.3390/ijerph20042813.
The association of the paraoxonase 1 Q192R polymorphism with coronary artery disease (CAD) and cardiometabolic risk factors in Iranian patients suspected of CAD.
Darand M, Salehi-Abargouei A, Vahidi Mehrjardi M, Feizi A, Seyedhossaini S, Askari G
Front Cardiovasc Med. 2023; 9:1037940.
PMID: 36741829
PMC: 9890597.
DOI: 10.3389/fcvm.2022.1037940.
Highly Dynamic Gene Family Evolution Suggests Changing Roles for PON Genes Within Metazoa.
Lucas S, Graham A, Presnell J, Clark N
Genome Biol Evol. 2023; 15(2).
PMID: 36718542
PMC: 9937041.
DOI: 10.1093/gbe/evad011.
Interactome of Paraoxonase PON2 Reveals New Pathways for Tumor Growth Regulation.
Karlov V, Pestov N, Shakhparonov M, Korneenko T
Dokl Biochem Biophys. 2023; 508(1):31-36.
PMID: 36653584
PMC: 9848704.
DOI: 10.1134/S1607672922700089.
Role of Single Nucleotide Polymorphism L55M in the Gene as a Risk and Prognostic Factor in Acute Coronary Syndrome.
Doneva-Basheva K, Gospodinov K, Tacheva T, Dimov D, Vlaykova T
Curr Issues Mol Biol. 2022; 44(12):5915-5932.
PMID: 36547064
PMC: 9776864.
DOI: 10.3390/cimb44120403.
Comparison of Follicular Fluid Paraoxonase 3 Level, Ovarian Hormones and Oocyte Quality between Fertile and Infertile Women.
Janati S, Behmanesh M, Najafzadehvarzi H, Nezami B, Mahsa Poormoosavi S
J Reprod Infertil. 2022; 23(3):192-198.
PMID: 36415493
PMC: 9666599.
DOI: 10.18502/jri.v23i3.10010.
The Paraoxanase 1 (PON1) Gene in the Context of Coronary Artery Disease.
Pinheiro D, Jesuino R
Arq Bras Cardiol. 2022; 119(4):602-603.
PMID: 36287414
PMC: 9563891.
DOI: 10.36660/abc.20220645.
Examining the role of paraoxonase 2 in the dopaminergic system of the mouse brain.
Garrick J, Dao K, Costa L, Marsillach J, Furlong C
BMC Neurosci. 2022; 23(1):52.
PMID: 36056313
PMC: 9438175.
DOI: 10.1186/s12868-022-00738-4.
Effect of Carotenoids on Paraoxonase-1 Activity and Gene Expression.
Otocka-Kmiecik A
Nutrients. 2022; 14(14).
PMID: 35889799
PMC: 9318174.
DOI: 10.3390/nu14142842.
The Relationship between Cancer and Paraoxonase 1.
Medina-Diaz I, Ponce-Ruiz N, Rojas-Garcia A, Zambrano-Zargoza J, Bernal-Hernandez Y, Gonzalez-Arias C
Antioxidants (Basel). 2022; 11(4).
PMID: 35453382
PMC: 9028432.
DOI: 10.3390/antiox11040697.
Association and Gene Polymorphisms with Polycystic Ovary Syndrome in Saudi Women.
Alkhuriji A, Alomar S, Babay Z, El-Khadragy M, Alsharidah A, Hanan A
Mol Syndromol. 2022; 13(2):117-122.
PMID: 35414808
PMC: 8928176.
DOI: 10.1159/000519527.
A PON for All Seasons: Comparing Paraoxonase Enzyme Substrates, Activity and Action including the Role of PON3 in Health and Disease.
Mohammed C, Lamichhane S, Connolly J, Soehnlen S, Khalaf F, Malhotra D
Antioxidants (Basel). 2022; 11(3).
PMID: 35326240
PMC: 8945423.
DOI: 10.3390/antiox11030590.
Insights into the role of paraoxonase 2 in human pathophysiology.
Parween F, Gupta R
J Biosci. 2022; 47.
PMID: 35092416
PMC: 8721187.
Serum Paroxonase 1 level may be an Indicator and Predictor of the Severity of Androgenetic Alopecia.
Tantawy M, Khabir A, Mahsoub N, Zohdy M
Int J Trichology. 2021; 13(6):26-31.
PMID: 34934297
PMC: 8647709.
DOI: 10.4103/ijt.ijt_128_20.